PatientsVille.com Logo

Terbinafine Side Effects

PatientsVille

Common Terbinafine Side Effects


The most commonly reported Terbinafine side effects (click to view or check a box to report):

Dysgeusia (85)
Ageusia (80)
Dizziness (61)
Rash (60)
Depression (57)
Nausea (51)
Malaise (47)
Pruritus (44)
Headache (41)
Anxiety (36)
Weight Decreased (33)
Urticaria (33)
Fatigue (32)
Liver Function Test Abnormal (32)
Erythema (32)
Paraesthesia (31)
Skin Exfoliation (29)
Myalgia (28)
Diarrhoea (28)
Panic Attack (27)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Terbinafine Side Effects Reported to FDA



Terbinafine Side Effect Report#9992113
Pancreatitis, Cholelithiasis, Gastrointestinal Inflammation, Liver Function Test Abnormal
This is a report of a 66-year-old male patient (weight: NA) from GB, suffering from the following health symptoms/conditions: onychomycosis, who was treated with Terbinafine (dosage: 250 Mg, Unk, start time:
Sep 24, 2013), combined with:
  • Covonia Bronchial (Unk Ukn, Unk)
  • Ibuprofen (Unk Ukn, Unk)
and developed a serious reaction and side effect(s): Pancreatitis, Cholelithiasis, Gastrointestinal Inflammation, Liver Function Test Abnormal after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Terbinafine treatment in male patients, resulting in Pancreatitis side effect. The patient was hospitalized.
Terbinafine Side Effect Report#9980877
Blister, Rash Macular
This report suggests a potential Terbinafine (terbinafine) Blister side effect(s) that can have serious consequences. A 31-year-old male patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: NA and used Terbinafine (terbinafine) (dosage: NA) starting
Nov 20, 2013. After starting Terbinafine (terbinafine) the patient began experiencing various side effects, including: Blister, Rash MacularAdditional drugs used concurrently:
  • Betamethasone Valerate (betamethasone Valerate)
  • E45 (akwa Tears /01635801/)
  • Mometasone (mometasone)
Although Terbinafine (terbinafine) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Blister, may still occur.
Terbinafine Side Effect Report#9931139
Biliary Cirrhosis Primary, Urticaria, Tryptase Increased, Pruritus, Autoimmune Disorder, Hepatic Enzyme Increased
This Biliary Cirrhosis Primary problem was reported by a health professional from CH. A 29-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: antifungal treatment. On NS this consumer started treatment with Terbinafine (dosage: NA). The following drugs were being taken at the same time: NA. When using Terbinafine, the patient experienced the following unwanted symptoms/side effects: Biliary Cirrhosis Primary, Urticaria, Tryptase Increased, Pruritus, Autoimmune Disorder, Hepatic Enzyme IncreasedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Biliary Cirrhosis Primary, may become evident only after a product is in use by the general population.
Terbinafine Side Effect Report#9924380
Blister, Rash Macular, Rash Pustular
This Blister side effect was reported by a physician from GB. A 31-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Terbinafine (drug dosage: NA), which was initiated on
Oct 25, 2013. Concurrently used drugs:
  • Betamethasone Valerate
  • E45
  • Mometasone
.After starting to take Terbinafine the consumer reported adverse symptoms, such as: Blister, Rash Macular, Rash PustularThese side effects may potentially be related to Terbinafine.
Terbinafine Side Effect Report#9922578
Blister, Rash Pustular, Rash Macular
This is a report of a 31-year-old male patient (weight: NA) from GB, suffering from the following health symptoms/conditions: NA, who was treated with Terbinafine (dosage: Unk Ukn, Unk, start time:
Oct 25, 2013), combined with:
  • Betamethasone Valerate (Unk Ukn, Unk)
  • E45 (Unk Ukn, Unk)
  • Mometasone (Unk Ukn, Unk)
  • Cetraben (Unk Ukn, Unk)
and developed a serious reaction and side effect(s): Blister, Rash Pustular, Rash Macular after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Terbinafine treatment in male patients, resulting in Blister side effect.
Terbinafine Side Effect Report#9919949
Subacute Cutaneous Lupus Erythematosus, Erythema Multiforme
This report suggests a potential Terbinafine Death side effect(s) that can have serious consequences. A 78-year-old male patient (weight: NA) from DK was diagnosed with the following symptoms/conditions: NA and used Terbinafine (dosage: NA) starting NS. After starting Terbinafine the patient began experiencing various side effects, including: Subacute Cutaneous Lupus Erythematosus, Erythema MultiformeAdditional drugs used concurrently:
  • Lansoprazole (Unk)
Although Terbinafine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.
Terbinafine Side Effect Report#9916201
Epilepsy
This Epilepsy problem was reported by a physician from GB. A 56-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: onychomycosis. On
Jul 03, 2013 this consumer started treatment with Terbinafine (dosage: NA). The following drugs were being taken at the same time:
  • Sildenafil
When using Terbinafine, the patient experienced the following unwanted symptoms/side effects: EpilepsyAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Epilepsy, may become evident only after a product is in use by the general population.
Terbinafine Side Effect Report#9915738
Dysgeusia, Headache, Viith Nerve Paralysis
This Dysgeusia side effect was reported by a consumer or non-health professional from GB. A 48-year-old female patient (weight:NA) experienced the following symptoms/conditions: onychomycosis.The patient was prescribed Terbinafine (terbinafine) (drug dosage: NA), which was initiated on
Nov 15, 2013. Concurrently used drugs: NA..After starting to take Terbinafine (terbinafine) the consumer reported adverse symptoms, such as: Dysgeusia, Headache, Viith Nerve ParalysisThese side effects may potentially be related to Terbinafine (terbinafine). The patient was hospitalized.
Terbinafine Side Effect Report#9914799
Epilepsy
This is a report of a 56-year-old male patient (weight: NA) from GB, suffering from the following health symptoms/conditions: onychomycosis, who was treated with Terbinafine (dosage: 250 Milligram Daily;, start time:
Jul 03, 2013), combined with:
  • Sildenafil
and developed a serious reaction and side effect(s): Epilepsy after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Terbinafine treatment in male patients, resulting in Epilepsy side effect.
Terbinafine Side Effect Report#9912066
Viith Nerve Paralysis, Headache, Dysgeusia
This report suggests a potential Terbinafine Hydrochloride Viith Nerve Paralysis side effect(s) that can have serious consequences. A 48-year-old female patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: onychomycosis and used Terbinafine Hydrochloride (dosage: NA) starting
Nov 15, 2013. After starting Terbinafine Hydrochloride the patient began experiencing various side effects, including: Viith Nerve Paralysis, Headache, DysgeusiaAdditional drugs used concurrently: NA.The patient was hospitalized. Although Terbinafine Hydrochloride demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Viith Nerve Paralysis, may still occur.
Terbinafine Side Effect Report#9907306
Depression, Catatonia
This Depression problem was reported by a health professional from NL. A 64-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: onychomycosis. On
Nov 26, 2013 this consumer started treatment with Terbinafine (dosage: 1 Keer Per Dag 1 Stuk(s)). The following drugs were being taken at the same time: NA. When using Terbinafine, the patient experienced the following unwanted symptoms/side effects: Depression, CatatoniaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Depression, may become evident only after a product is in use by the general population.
Terbinafine Side Effect Report#9899339
Hypersensitivity, Depression, Skin Disorder, Skin Exfoliation
This Hypersensitivity side effect was reported by a pharmacist from NL. A 64-year-old male patient (weight:NA) experienced the following symptoms/conditions: fungal infection.The patient was prescribed Terbinafine (drug dosage: 1 Keer Per Dag 1 Stuk(s)), which was initiated on
Jan 14, 2011. Concurrently used drugs:
  • Simvastatine
  • Acetylsalicylzuur
.After starting to take Terbinafine the consumer reported adverse symptoms, such as: Hypersensitivity, Depression, Skin Disorder, Skin ExfoliationThese side effects may potentially be related to Terbinafine. The patient was hospitalized.
Terbinafine Side Effect Report#9894158
Viith Nerve Paralysis, Headache, Dysgeusia
This is a report of a 48-year-old female patient (weight: NA) from GB, suffering from the following health symptoms/conditions: onychomycosis, who was treated with Terbinafine (dosage: NA, start time:
Nov 15, 2013), combined with: NA. and developed a serious reaction and side effect(s): Viith Nerve Paralysis, Headache, Dysgeusia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Terbinafine treatment in female patients, resulting in Viith Nerve Paralysis side effect. The patient was hospitalized.
Terbinafine Side Effect Report#9888555
Epilepsy
This report suggests a potential Terbinafine Epilepsy side effect(s) that can have serious consequences. A 56-year-old male patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: onychomycosis and used Terbinafine (dosage: 250 Mg, Qd) starting
Jul 03, 2013. After starting Terbinafine the patient began experiencing various side effects, including: EpilepsyAdditional drugs used concurrently:
  • Sildenafil (Unk Ukn, Unk)
Although Terbinafine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Epilepsy, may still occur.
Terbinafine Side Effect Report#9881190
Viith Nerve Paralysis, Headache, Dysgeusia
This Viith Nerve Paralysis problem was reported by a consumer or non-health professional from GB. A 48-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: onychomycosis. On
Nov 15, 2013 this consumer started treatment with Terbinafine (dosage: NA). The following drugs were being taken at the same time: NA. When using Terbinafine, the patient experienced the following unwanted symptoms/side effects: Viith Nerve Paralysis, Headache, DysgeusiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Viith Nerve Paralysis, may become evident only after a product is in use by the general population.
Terbinafine Side Effect Report#9855293
Stevens-johnson Syndrome, Eczema, Insomnia, Stress
This Stevens-johnson Syndrome side effect was reported by a physician from GB. A 78-year-old male patient (weight:NA) experienced the following symptoms/conditions: tinea infection.The patient was prescribed Terbinafine (drug dosage: NA), which was initiated on
Sep 14, 2013. Concurrently used drugs: NA..After starting to take Terbinafine the consumer reported adverse symptoms, such as: Stevens-johnson Syndrome, Eczema, Insomnia, StressThese side effects may potentially be related to Terbinafine.
Terbinafine Side Effect Report#9850030
Pulse Pressure Increased, Arteritis, Muscle Spasms, Pain Of Skin, Pain, Headache
This is a report of a 62-year-old female patient (weight: NA) from GB, suffering from the following health symptoms/conditions: onychomycosis, who was treated with Terbinafine (dosage: 250 Mg, Unk, start time:
Dec 30, 2013), combined with:
  • Amitriptyline (10 Mg, Qd At Night)
and developed a serious reaction and side effect(s): Pulse Pressure Increased, Arteritis, Muscle Spasms, Pain Of Skin, Pain, Headache after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Terbinafine treatment in female patients, resulting in Pulse Pressure Increased side effect.
Terbinafine Side Effect Report#9849415
Dysgeusia, Ageusia, Food Aversion, Aptyalism, Dysphagia, Oropharyngeal Pain
This report suggests a potential Terbinafine Hcl Dysgeusia side effect(s) that can have serious consequences. A 65-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Terbinafine Hcl (dosage: NA) starting
Oct 04, 2013. After starting Terbinafine Hcl the patient began experiencing various side effects, including: Dysgeusia, Ageusia, Food Aversion, Aptyalism, Dysphagia, Oropharyngeal PainAdditional drugs used concurrently:
  • Estradiol
  • Diltiazem Hcl
  • Hydrochlorothiazide
  • Baby Aspirin
  • Citracal D
  • Centrum Specialist Heart
Although Terbinafine Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dysgeusia, may still occur.
Terbinafine Side Effect Report#9846505
Rash, Excoriation, Dry Skin, Erythema
This Rash problem was reported by a pharmacist from GB. A 88-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: fungal infection. On
Dec 19, 2013 this consumer started treatment with Terbinafine (terbinafine) (dosage: NA). The following drugs were being taken at the same time:
  • Aspirin (acetylsalicylic Acid)
  • Diprobase (diprobase)
  • E45 (akwa Tears)
  • Enalapril (enalapril)
  • Flucloxacillin ( Flucloxacillin)
  • Metformin (metformin)
  • Miconazole (miconazole)
  • Paracetamol (paracetamol)
When using Terbinafine (terbinafine), the patient experienced the following unwanted symptoms/side effects: Rash, Excoriation, Dry Skin, ErythemaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Rash, may become evident only after a product is in use by the general population.
Terbinafine Side Effect Report#9839746
Arteritis, Pain, Headache, Pulse Pressure Increased, Pain Of Skin, Muscle Spasms
This Arteritis side effect was reported by a physician from GB. A 62-year-old female patient (weight:NA) experienced the following symptoms/conditions: onychomycosis.The patient was prescribed Terbinafine (drug dosage: NA), which was initiated on
Dec 30, 2013. Concurrently used drugs:
  • Amitriptyline
.After starting to take Terbinafine the consumer reported adverse symptoms, such as: Arteritis, Pain, Headache, Pulse Pressure Increased, Pain Of Skin, Muscle SpasmsThese side effects may potentially be related to Terbinafine.
Terbinafine Side Effect Report#9833549
Dermatitis Exfoliative, Arthralgia, Erythema, Renal Failure Acute, Renal Impairment, Local Swelling
This is a report of a 77-year-old male patient (weight: NA) from GB, suffering from the following health symptoms/conditions: onychomycosis, who was treated with Terbinafine (dosage: NA, start time:
Aug 19, 2013), combined with:
  • Flucloxacillin
  • Penicillin V
  • Atorvastatin
  • Clopidogrel
  • Metformin
and developed a serious reaction and side effect(s): Dermatitis Exfoliative, Arthralgia, Erythema, Renal Failure Acute, Renal Impairment, Local Swelling after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Terbinafine treatment in male patients, resulting in Dermatitis Exfoliative side effect. The patient was hospitalized and became disabled.
Terbinafine Side Effect Report#9825114
Erythema, Dry Skin, Excoriation
This report suggests a potential Terbinafine Erythema side effect(s) that can have serious consequences. A 88-year-old female patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: fungal infection and used Terbinafine (dosage: NA) starting
Dec 17, 2013. After starting Terbinafine the patient began experiencing various side effects, including: Erythema, Dry Skin, ExcoriationAdditional drugs used concurrently:
  • Aspirin
  • Diprobase
  • E45
  • Enalapril
  • Flucloxacillin
  • Metformin
  • Miconazole
  • Paracetamol
The patient was hospitalized. Although Terbinafine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Erythema, may still occur.
Terbinafine Side Effect Report#9821162
Orchitis, Dermatitis Exfoliative, Groin Pain, Renal Failure Acute, Hepatic Function Abnormal, Thrombocytopenia, Atrial Fibrillation, Respiratory Failure
This Orchitis problem was reported by a pharmacist from GB. A 57-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: fungal infection. On
Sep 24, 2013 this consumer started treatment with Terbinafine (dosage: NA). The following drugs were being taken at the same time:
  • Phenobarbital (phenobarbital)
When using Terbinafine, the patient experienced the following unwanted symptoms/side effects: Orchitis, Dermatitis Exfoliative, Groin Pain, Renal Failure Acute, Hepatic Function Abnormal, Thrombocytopenia, Atrial Fibrillation, Respiratory FailureAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Orchitis, may become evident only after a product is in use by the general population.
Terbinafine Side Effect Report#9820445
Renal Failure Acute
This Renal Failure Acute side effect was reported by a health professional from FR. A 25-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Terbinafine (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Terbinafine the consumer reported adverse symptoms, such as: Renal Failure AcuteThese side effects may potentially be related to Terbinafine. The patient was hospitalized.
Terbinafine Side Effect Report#9816689
Dermatitis Exfoliative, Thrombocytopenia, Hepatic Function Abnormal, Respiratory Failure, Renal Failure Acute, Groin Pain, Orchitis, Atrial Fibrillation
This is a report of a 57-year-old male patient (weight: NA) from GB, suffering from the following health symptoms/conditions: fungal infection,epilepsy, who was treated with Terbinafine (dosage: 250 Milligram Daily; (note: 13 Of 28 Tablets Supplied Remain I.e. Not Taken), start time:
Sep 24, 2013), combined with:
  • Phenobarbital
and developed a serious reaction and side effect(s): Dermatitis Exfoliative, Thrombocytopenia, Hepatic Function Abnormal, Respiratory Failure, Renal Failure Acute, Groin Pain, Orchitis, Atrial Fibrillation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Terbinafine treatment in male patients, resulting in Dermatitis Exfoliative side effect.

1 of 42 


The appearance of Terbinafine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


What are common Terbinafine Side Effects for Women?

Women Side EffectsReports
Dysgeusia 76
Ageusia 59
Malaise 40
Dizziness 39
Nausea 29
Weight Decreased 29
Headache 28
Pruritus 27
Depression 26
Rash 23

What are common Terbinafine Side Effects for Men?

Men Side EffectsReports
Rash 35
Depression 31
Pancreatitis 25
Ageusia 21
Nausea 21
Liver Function Test Abnormal 20
Paraesthesia 20
Dizziness 19
Myalgia 18
Skin Exfoliation 18

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Terbinafine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Terbinafine Side Effects

    Did You Have a Terbinafine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Terbinafine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Terbinafine Safety Alerts, Active Ingredients, Usage Information

    NDC0363-2083
    TypeHUMAN OTC DRUG
    Proprietary NameTerbinafine Hydrochloride
    NameTerbinafine Hydrochloride
    Dosage FormCREAM
    RouteTOPICAL
    On market since20070702
    LabelerWalgreen Company
    Active Ingredient(s)TERBINAFINE HYDROCHLORIDE
    Strength(s)1
    Unit(s)g/100g
    Pharma Class

    More About Terbinafine

    Side Effects reported to FDA: 1036

    Terbinafine safety alerts: 2001 2000

    Reported deaths: 23

    Reported hospitalizations: 126

    Lamisil (terbinafine hydrochloride)

    Sporanox (itraconazole)

    Audience: Dermatologists and other healthcare professionals

    FDA is issuing a public health advisory concerning Sporanox and Lamisil, systemic drug therapies to treat onychomycosis (fungal nail infections). Healthcare professionals are notified of the possible association of serious cardiac adverse events with the administration of Sporanox and hepatic adverse events with the administration of both Sporanox and Lamisil. New labeling for both Sporanox and Lamisil recommends that healthcare providers obtain nail specimens for laboratory testing prior to prescribing the medications for onychomycosis to confirm the diagnosis. FDA's concerns do NOT apply to the over-the-counter versions of Lamisil, which are topical creams.

    [May 11, 2001 - Letter - Novartis Pharmaceuticals Corp.]
    [May 09, 2001 - Letter - Janssen Pharmaceutica Products, L.P.]
    [May 09, 2001 - Public Health Advisory - FDA]
    [May 09, 2001 - Questions and Answers - FDA]
    [May 09, 2001 - Revised Sporanox Capsules Label - Janssen Pharmaceutica Products, L.P.]

     

    Latest Terbinafine clinical trials